Well out of my expertise I'm afraid, CP. I was surprised to hear Gary say the FDA only required 12 patients for our Ph2, but SNT went that bit extra with 15, so not really sure what to expect when they speak to the FDA to design the Ph3, following the Ph2 results. I'm sure it will require a larger patient pool, but just how large I don't know.
Add to My Watchlist
What is My Watchlist?
